Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PDRDX | 11.45 | 0.02 | +0.17% |
| Principal Diversified Real Asset Instl | |||
| VLAAX | 45.91 | -0.43 | -0.93% |
| Value Line Asset Allocation Investor | |||
| WAEMX | 2.99 | -0.03 | -0.99% |
| Wasatch Emerging Markets Small Cap Inv | |||
| MEYWX | 12.89 | -0.24 | -1.83% |
| Manning & Napier Equity Series W | |||
| APGAX | 101.16 | -2.75 | -2.65% |
| AB Large Cap Growth A | |||
A.I.dvisor tells us that NDVAF and ZLSCF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDVAF and ZLSCF's prices will move in lockstep.
| Ticker / NAME | Correlation To NDVAF | 1D Price Change % | ||
|---|---|---|---|---|
| NDVAF | 100% | N/A | ||
| ZLSCF - NDVAF | 25% Poorly correlated | N/A | ||
| MEDIF - NDVAF | 9% Poorly correlated | -1.64% | ||
| MRMD - NDVAF | 4% Poorly correlated | -6.76% | ||
| OASMY - NDVAF | 2% Poorly correlated | N/A | ||
| NXEN - NDVAF | 2% Poorly correlated | N/A | ||
More | ||||